digital therapeutics

By Dave Muoio 02:08 pm August 20, 2019
ATENTIV, maker of a video game-based intervention for ADHD, has partnered with Children’s Specialized Hospital’s Center for Discovery, Innovation and Development (CDID) to explore a novel care model blending both behavioral and primary care. Of particular note, ATENTIV and CDID, part of the RWJBarnabas Health system in New Jersey, will be investigating how to deploy the therapy, called...
By Dave Muoio 02:00 pm August 6, 2019
Chicago-based metaMe Health, a startup focused on behavioral digital treatments gastrointestinal conditions, has raised $3.8 million in seed funding. LionBird Ventures led the round, which also saw contributions from Hemi Ventures and other unnamed backers. WHAT THEY DO The company’s lead product is Regulora, a treatment tackling the cognitive, behavioral and affective factors that can trigger...
By Dave Muoio 02:32 pm July 26, 2019
In many respects, the pharma industry’s operations are still in the early stages of technological  revolution, and there’s no better example of this than its gradual adoption of digital health and digital therapeutics. On one hand, more and more groups are regularly striking new partnerships that supplement existing drug treatments with digital tools, while Novartis continues its work with Pear...
By Dave Muoio 03:58 pm July 25, 2019
IPO fever is hitting a bit of a frenzy amidst a slew of recent listings, and with it has come a renewed focus on the exact boundaries of digital health — or, alternately, of health-tech, connected health, eHealth, or any of the other myriad monikers for the intersections of healthcare, technology and innovation. As observers from various mainstream and niche industries have flocked to discuss ...
By Dave Muoio 03:59 pm July 22, 2019
Prescription digital therapeutics company Pear Therapeutics announced late last week that it has filed an FDA marketing authorization for Somryst, its digital cognitive behavioral therapy for the treatment of adults with chronic insomnia and depression. While an approval from the agency would mark the third authorized prescription digital therapeutic for Pear — behind reSET for substance use...
By Laura Lovett 04:15 pm July 1, 2019
It would be hard to discuss healthcare trends without talking about what this means for the behemoth pharma industry. Recently, new kid on the block digital health has started to turn heads in across this well-established sector with its potential for improving R&D, tracking real-world evidence and even creating a new type of medicine with digital therapeutics.  While digital promises the...
By Dave Muoio 03:12 pm June 12, 2019
Yesterday, CVS Health unveiled Vendor Benefit Management, a new service that will help CVS Caremark pharmacy benefit management (PBM) clients roll out and manage third-party health products. As the service is applicable to both digital and non-digital health and wellness products, the company has decided to inaugurate its initiative by announcing Big Health — maker of the CBT-based sleep app...
By Dave Muoio 03:52 pm June 5, 2019
Healthcare is in the midst of a digital shift. Artificial intelligence offers physicians providers an new resource when making decisions, new data streams promise hyper-personalized treatments and digital therapeutics evangelists see are hawking the novel treatments as a companion, or even a replacement, to traditional biologic treatments. All in all, it’s a future that hopes to empower the...
By Dave Muoio 02:32 pm May 16, 2019
Express Scripts will be releasing a stand-alone formulary in 2020 that highlights vetted digital health tools for the pharmacy benefit management firm’s payer and consumer customers, according to an announcement released this morning. The company said that it will be treating the new formulary in much the same way it would a similar resource for traditional medications. To be included, a digital...
By Joe Slavinsky 01:58 pm May 16, 2019
About the author: Joe Slavinsky leads business development efforts with pharmaceutical, biotechnology and medical technology companies in his VP position at Propeller Health. A former epidemiologist, he worked at a hedge fund (Citadel) and an investment bank (Thomas Weisel Partners) as an equity research analyst covering small/mid-cap biotechnology companies. Joe joined Propeller from Gilead...